Cytosite Biopharma Inc.   Report issue

For profit Phase 1
Founded: Sudbury MA United States (2016)
Status: No NME R&D (2016)

Organization Overview

First Clinical Trial
2019
NCT04169321
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Cytosite Biopharma Inc.